** Shares of Inari Medical rise 27.5% to a near one-year high of $63.47
** Medical device maker Stryker is in advanced talks to acquire NARI, which makes devices to treat patients with venous diseases, Reuters reports, citing people familiar with the matter
** If the talks are successful, a deal could be announced as soon as this week, the report said
** Deal would bolster SYK's efforts to build out its offerings to treat a condition called venous thromboembolism, where a blood clot forms in a vein, and other venous diseases
** NARI stock fell 21.4% in 2024
(Reporting by Puyaan Singh)
((Puyaan.Singh@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。